Navigation Links
Pharmacyclics Identifies Functional Biomarkers for its Novel HDAC,Inhibitor and Demonstrates Preclinical Anti-Tumor Activity with,Bruton's Tyrosine Kinase Inhibitors

/font>


'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Pharmacyclics Announces Interim Results From Two Ongoing Phase 2 Trials Supporting Potential of Xcytrin Plus Chemotherapy to Treat Recurrent Non-Small Cell Lung Cancer
2. Pharmacyclics Announces Promising Results From Phase 2 Clinical Trial of Xcytrin in Recurrent, Metastatic Non-Small Cell Lung Cancer
3. Pharmacyclics Announces Presentations and Published Abstracts on Xcytrin at The 2007 American Society of Clinical Oncology Annual Meeting
4. Pharmacyclics Announces Presentations on Its Novel and Selective HDAC and Brutons Tyrosine Kinase Inhibitor Compounds
5. CV Therapeutics Identifies Potential Anti-Diabetic Mechanism of Action for Ranexa
6. Anacor Identifies a Novel Mechanism for Its Lead Anti-Fungal Drug, AN2690; Findings Published in Science
7. ARRIVE Registry Analysis Identifies Predictors of Stent Thrombosis in Real-World Use of Drug-Eluting Stents
8. NIDA Study Identifies Genes That Might Help Some People Abstain from Smoking
9. Rigel Ubiquitin Ligase Program Identifies Molecules With Anti-HIV Activity
10. Study in Cell by Magen BioSciences Co-Founder David E. Fisher Identifies New Roles in Skin Cancer Prevention for Key Tumor Suppressor Protein
11. BioLineRx Presents Data on BL-1040 at Cardiovascular Revascularization Therapies Conference Demonstrating Potential to Reduce Deterioration of Infarcted Heart Tissue and Maintain Functionality

Post Your Comments:
(Date:11/25/2009)...v. 25 Praxis Electronic Medical Re...n Academy of Family Physicians, (AAFP) Family Prac...urvey for improving medical quality, health mainte...w ARRA Stimulus legislation. Praxis also ranked #1... effect in determining their salary. Finally, Prax...
(Date:11/25/2009)... Pharmasset, Inc. (Nasda...y committed to discovering, developing and commerc...ported financial results for the fiscal year ended...set held $58.4 million in cash, cash equivalents a... and 2009 Highlights ,, RG7128 ,, Phase...
(Date:11/25/2009)... The FDA granted traditional appro...n-nucleoside reverse transcriptase inhibitor (NNRT...ated for use in treatment-experienced adults who a...ns resistant to an NNRTI and other antiretroviral ...n 48-week data from two Phase 3 studies known as D...
Breaking Medicine Technology:Praxis EMR Wins Top Rankings in 2009 AAFP EHR User Satisfaction Survey 2Pharmasset Reports Fiscal Year End 2009 Financial Results 2Pharmasset Reports Fiscal Year End 2009 Financial Results 3Pharmasset Reports Fiscal Year End 2009 Financial Results 4Pharmasset Reports Fiscal Year End 2009 Financial Results 5Pharmasset Reports Fiscal Year End 2009 Financial Results 6Pharmasset Reports Fiscal Year End 2009 Financial Results 7Pharmasset Reports Fiscal Year End 2009 Financial Results 8Pharmasset Reports Fiscal Year End 2009 Financial Results 9Pharmasset Reports Fiscal Year End 2009 Financial Results 10U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 2U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 3U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 4U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 5Measuring intellectual disability 8977 1Measuring intellectual disability 8977 2M2SYS Technology to Offer Desktop Biometric Technology to Kronos Customers 8975 1M2SYS Technology to Offer Desktop Biometric Technology to Kronos Customers 8975 2BD Announces CE Marking of BD ProbeTec 26amp 3B 238482 3B Qx Amplified Assays to Improve Detection of Chlamydia trachomatis and Neisseria gonorrhoeae 49844 1BD Announces CE Marking of BD ProbeTec 26amp 3B 238482 3B Qx Amplified Assays to Improve Detection of Chlamydia trachomatis and Neisseria gonorrhoeae 49844 2BD Announces CE Marking of BD ProbeTec 26amp 3B 238482 3B Qx Amplified Assays to Improve Detection of Chlamydia trachomatis and Neisseria gonorrhoeae 49844 3BD Announces CE Marking of BD ProbeTec 26amp 3B 238482 3B Qx Amplified Assays to Improve Detection of Chlamydia trachomatis and Neisseria gonorrhoeae 49844 4
...IEW, Calif., June 22, 2007 /PRNewswire/ -- MAP,Pha...esent Phase 2,data from its Unit Dose Budesonide (...the World Asthma Meeting at the Lutfi Kirdar,Conve... The oral and poster presentation entitled, "Effic...lation of budesonide for,nebulized delivery in a 6...
... Announces Bioinformatics Partnership with,Illumin...une 21, 2007,-GenoLogics, a leading developer of l... sciences research, today announced that,it has pe...technology partner and participant in IlluminaConn... by Illumina to advance,data integration and analy...
Other Medicine Technology:MAP Pharmaceuticals to Present Unit Dose Budesonide Phase 2,Clinical Data at the World Asthma Meeting 2GenoLogics Announces Bioinformatics Partnership with Illumina 2GenoLogics Announces Bioinformatics Partnership with Illumina 3
(Date:11/29/2009)...tors unaware the sleep disorder boosts urine produ...(HealthDay News) -- People who wake up during the ...rological problem. Sleep apnea, a breathing-relate...tudy suggests that nighttime urination, or nocturi...bstructive sleep apnea, a disorder in which soft t...
(Date:11/28/2009)...ffenders were more likely to consider change after..., , FRIDAY, Nov. 27 (HealthDay News) -- ...nsider why they should stop their dangerous behavi...s, researchers have found. , The new study incl...ile-impaired convictions, who were randomly assign...
(Date:11/27/2009)... Biotech firm Replikins Ltd. toda...N1 virus genomic data. It shows that the lethalit....d. 4.5) during the virus,s current outbreak in th...is week of 2.0 (s.d. 0.1). The H1N1 infectivity co... Boston (PRWEB) November 27, 2009 -- Biot...
(Date:11/27/2009)..., KIBBUTZ SHAMIR, Israel, Nov. 27 /PRNewswire-Fir...SHMR ) ( "Shamir" ), a leading provider of innovat... market, announced today that its board of directo...egate amount of US$ 10 million (approximately NIS ...sentative rate of exchange), or approximately US$ ...
(Date:11/27/2009)... Voyant Health™ announced t... has licensed its TraumaCad Enterprise orthopedic ...low solution. , (PRWEB) N... today that Spectrum Health (Grand Rapids, Michiga...c templating solution and its TraumaCad Extend wor...
Breaking Medicine News(10 mins):Health News:Sleep Apnea May Cause Nighttime Urination 2Health News:Sleep Apnea May Cause Nighttime Urination 3Health News:Drunk Drivers May Respond to Brief Motivational Interview 2Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 2Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 3Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 4Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 5Health News:Shamir Optical Industry Ltd. Announces Declaration of a Cash Dividend 2Health News:Shamir Optical Industry Ltd. Announces Declaration of a Cash Dividend 3Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 2Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 3
...POLIS, Dec. 8 A mural on a 1,230-foot-long wall,a...Indianapolis, has achieved,recognition as a new Gu...fication projects completed in partnership with Ke...ld last May. , Lilly and KIB submitted the m...
...LE, Calif., Dec. 8 Expresso Fitness(R), the leadi...tness systems, announced today,that it has complet...$14M.,The capital will be used to fuel Expresso,s ...xpresso. The equity round was,joined by all exist...
...EE, Dec. 8 Aurora Health Care and Associated Surg...premier ambulatory surgery centers, announced toda... the two organizations jointly operate the surgery...nce the quality of care for patients," said James ...
...rts are recommending that a malaria vaccine progre...l of the RTS, S/AS01E malaria vaccine among 5-17 m... Kenya, which is reported today in the New Englan...inistration of the RTS, S/AS02 malaria vaccine thr...
..., Dec. 8 Americans United for Life (AUL) condemns...e state have a right to die by assisted suicide, a...ontana State Supreme Court. , , Dr. Charmai...ses in Oregon where patients are denied state insu...
...ic Injury Protection Program Expands Benefits , ...s Affairs (VA) announced some severely injured mil...improvements to the Servicemembers, Group Life Ins...y personnel and their families," said Secretary of...
Other Medicine News:Health News:Lilly Global Day of Service Receives National and Local Recognition 2Health News:Lilly Global Day of Service Receives National and Local Recognition 3Health News:Expresso Fitness(R) Receives Additional $14 Million in Funding 2Health News:Expresso Fitness(R) Receives Additional $14 Million in Funding 3Health News:Expresso Fitness(R) Receives Additional $14 Million in Funding 4Health News:Aurora and Associated Surgical & Medical Specialists Announce Surgery Center Joint Venture 2Health News:Promising trials of malaria vaccine lead to calls for Phase 3 development 2Health News:Promising trials of malaria vaccine lead to calls for Phase 3 development 3Health News:Americans United For Life Denounces Montana Court's Assisted Suicide Decision, Urges Appeal 2Health News:VA Announces Changes to Servicemembers' Group Life Insurance 2
Shahinian Lacrimal Cannula
Solo-Care Multipurpose Solution
Graether Collar Button On Handle
Graether Irrigating Collar Button
Medicine Products: